Defunct Company
Total Trials
24
As Lead Sponsor
0
As Collaborator
Total Enrollment
4,555
NCT00936169
Angiography Versus (vs) IVUS Optimisation
Phase: N/A
Role: Collaborator
Start: May 31, 2008
Completion: Jul 31, 2011
NCT01239654
Activity of Platelets After Inhibition and Cardiovascular Events Optical Coherence Tomography Study
Phase: Phase 3
Start: Sep 30, 2010
Completion: Aug 31, 2011
NCT01924377
Characterization and Elimination of Mother Rotors
Start: May 28, 2013
Completion: Jul 25, 2018
NCT03210480
SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)
Phase: Phase 4
Start: Mar 28, 2017
Completion: Sep 20, 2019
NCT03186378
Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.
Phase: Phase 2
Start: Jun 8, 2017
Completion: Jun 25, 2018
NCT03331276
Growth and Safety Study of an Infant Formula for Healthy Term Infants
Start: Sep 18, 2017
Completion: Jan 7, 2019
NCT03377803
Cantharidin Application in Molluscum Patients
Start: Feb 14, 2018
Completion: Sep 26, 2018
NCT03377790
Cantharidin Application in Molluscum Patients-1
Start: Mar 21, 2018
Completion: Nov 26, 2018
NCT03487549
Cantharidin and Occlusion in Verruca Epithelium
Start: Mar 27, 2018
Completion: Jul 15, 2019
NCT03507504
REspectful CAring for the AGitated Elderly
Start: Apr 19, 2018
Completion: Dec 31, 2021
NCT03399994
Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES
Start: May 21, 2018
Completion: Jul 26, 2022
NCT03745053
XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization
Start: Feb 5, 2019
Completion: Sep 2, 2023
NCT03981822
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
Start: Jun 25, 2019
Completion: Jul 8, 2020
NCT04218929
Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants
Start: Dec 10, 2019
Completion: Jun 11, 2021
NCT04238676
Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain
Phase: Phase 1/2
Start: Jan 20, 2020
Completion: Dec 9, 2024
NCT04389606
Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants
Start: May 12, 2020
NCT05954013
Advance Care Planning and Care Coordination for People With Parkinson's Disease
Start: Aug 6, 2020
Completion: Mar 17, 2023
NCT04593147
Phase II Growth and Safety Study of an Infant Formula for Healthy Term Infants
Start: Oct 14, 2020
Completion: Nov 9, 2021
NCT04671576
Growth and Safety Clinical Trial on a New Infant Formula.
Start: Feb 12, 2021
Completion: Aug 12, 2022
NCT05663294
PBI for Breast in Situ Carcinoma of Intermediate Low Risk As Local Adjuvant Treatment
Start: Jan 9, 2023
Completion: Dec 31, 2029
NCT05904288
DTx Algorithms for Personalized Parkinson's Disease Treatment and Medication Plan Optimization
Start: Oct 10, 2023
Completion: Oct 15, 2024
NCT06113705
Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
Start: Nov 1, 2023
Completion: Dec 31, 2026
NCT06486038
Quatitative MRI of the Spinal Cord in Cervical Myelopathy: Assessment of Microstuctural Damage for Outcome Improvement
Start: Apr 3, 2024
Completion: May 31, 2025
NCT06475456
Pilot Italian Cardiogenic Shock Initiative
Start: Dec 1, 2024
Completion: Dec 3, 2026